Supernus Pharmaceuticals reported $25.03M in Cost of Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbott ABT:US $ 4423M 520M
Adamas Pharmaceuticals ADMS:US 527K 142K
Aerie Pharmaceuticals AERI:US $ 6.18M 0.52M
Ani Pharmaceuticals ANIP:US $ 22.31M 2.33M
Antares Pharma ATRS:US $ 16.44M 0M
Aphria Inc APH:CN C$ 160.92M 13.78M
Aurora Cannabis Inc ACB:CN 115.68M 41.45M
Bristol Myers Squibb BMY:US $ 2451M 52M
Canopy Growth Corp WEED:CN C$ 108.97M 29.67M
Corcept Therapeutics CORT:US $ 1.38M 0.12M
Eisai 4523:JP Y 39250M 1899M
Eli Lilly And LLY:US $ 1953.2M 74.6M
Endo International Ordinary Shares ENDP:US $ 313.43M 23.44M
Gw Pharmaceuticals GWPH:US $ 11.81M 1.39M
Horizon Pharma HZNP:US $ 201M 100.63M
JAZZ PHA JAZZ:US $ 119.19M 79M
Lannett LCI:US $ 83.35M 2.56M
Pacira Pharmaceuticals PCRX:US $ 35.25M 3.9M
Perrigo Ordinary Shares PRGO:US $ 632.1M 9.5M
Pfizer PFE:US $ 6992M 2820M
Revance Therapeutics RVNC:US $ 5.43M 1.21M
Supernus Pharmaceuticals SUPN:US $ 25.03M 10.07M
Teva Pharmaceutical Industries TEVA:US $ 1987M 76M
United Therapeutics UTHR:US $ 37.2M 14.2M
Xeris Pharmaceuticals Inc XERS:US $ 3.38M 1.56M